Methylation profiling with a panel of cancer related genes: Association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer

被引:100
|
作者
Ronneberg, Jo Anders [2 ,3 ]
Fleischer, Thomas [2 ,3 ]
Solvang, Hiroko Kato [2 ]
Nordgard, Silje H. [2 ]
Edvardsen, Hege [2 ]
Potapenko, Ivan [2 ]
Nebdal, Daniel [2 ]
Daviaud, Christian [4 ]
Gut, Ivo [4 ]
Bukholm, Ida [5 ]
Naume, Bjorn [7 ]
Borresen-Dale, Anne-Lise [2 ,3 ]
Tost, Joerg [4 ]
Kristensen, Vessela [1 ,2 ,3 ,6 ]
机构
[1] Dept Clin Mol Biol Epi Gen, Lorenskog, Norway
[2] Oslo Univ Hosp Radiumhosp, Inst Canc Res, Dept Genet, N-0310 Oslo, Norway
[3] Univ Oslo, Fac Med, Inst Clin Med, N-0316 Oslo, Norway
[4] CEA, Inst Genom, Ctr Natl Genotypage, Lab Epigenet, F-91000 Evry, France
[5] Akershus Univ Hosp, Dept Surg, Nordbyhagen, Norway
[6] Univ Oslo, Fac Med, Inst Clin Epidemiol & Mol Biol EpiGen, N-0316 Oslo, Norway
[7] Oslo Univ Hosp Radiumhosp, Canc Clin, N-0310 Oslo, Norway
关键词
Breast cancer; DNA methylation; Homeobox genes; TP53; Epigenetics; Molecular classification; Gene expression; GENOME-WIDE ASSOCIATION; NF-KAPPA-B; BONE-MARROW; DNA HYPERMETHYLATION; MOLECULAR SUBTYPES; PROGNOSTIC-FACTORS; EPITHELIAL-CELLS; OSTEOPONTIN; EPIGENETICS; PROGRESSION;
D O I
10.1016/j.molonc.2010.11.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is a heterogeneous disease that can be divided in subtypes based on histology, gene expression profiles as well as differences in genomic aberrations. Distinct global DNA methylation profiles have been reported in normal breast epithelial cells as well as in breast tumors. However, the influence of the tumor methylome on the previously described subgroups of breast cancer is not fully understood. Here we report the DNA methylation profiles of 80 breast tumors using a panel of 807 cancer related genes interrogating 1505 CpG sites. We identified three major clusters based on the methylation profiles; one consisting of mainly tumors of myoepithelial origin and two other clusters with tumors of predominantly luminal epithelial origin. The clusters were different with respect to estrogen receptor status, TP53 status, ErbB2 status and grade. The most significantly differentially methylated genes including HDAC1, TFF1, OGG1, BMP3, FZD9 and HOXA11 were confirmed by pyrosequencing. Gene Ontology analysis revealed enrichment for genes involved in developmental processes including homeobox domain genes (HOXA9, HOXA11, PAX6, MYBL2, ISL1 and IPF1) and (ETS1, HDAC1, CREBBP, GAS7, SPI1 and TBX1). Extensive correlation to mRNA expression was observed. Pathway analyses identified a significant association with canonical (curated) pathways such as hepatic fibrosis including genes like EGF, NGFR and TNF, dendritic cell maturation and the NF-KB signaling pathway. Our results show that breast tumor expression subtypes harbor major epigenetic differences and tumors with similar gene expression profiles might belong to epigenetically different subtypes. Some of the transcription factors identified, with key roles in differentiation and development might play a role in inducing and maintaining the different phenotypes. (C) 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:61 / 76
页数:16
相关论文
共 50 条
  • [21] The TP53 gene polymorphisms and survival of sporadic breast cancer patients
    V. Bišof
    M. Peričić Salihović
    N. Smolej Narančić
    T. Škarić-Jurić
    J. Jakić-Razumović
    B. Janićijević
    P. Rudan
    Medical Oncology, 2012, 29 : 472 - 478
  • [22] The TP53 gene polymorphisms and survival of sporadic breast cancer patients
    Bisof, V.
    Salihovic, M. Pericic
    Narancic, N. Smolej
    Skaric-Juric, T.
    Jakic-Razumovic, J.
    Janicijevic, B.
    Rudan, P.
    MEDICAL ONCOLOGY, 2012, 29 (02) : 472 - 478
  • [23] TP53 mutation is an early event in breast cancer progression
    Zhou, W.
    Muggerud, A. A.
    Vu, P.
    Due, E. U.
    Sorlie, T.
    Borresen-Dale, A-L
    Warnberg, F.
    Langerod, A.
    CANCER RESEARCH, 2009, 69 (02) : 120S - 120S
  • [24] Abnormal expression or mutation of TP53 and HPV in vulvar cancer
    Ngan, HYS
    Cheung, ANY
    Liu, SS
    Yip, PSF
    Tsao, SW
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (03) : 481 - 484
  • [25] Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer
    Kim, Ji-Yeon
    Park, Kyunghee
    Jung, Hae Hyun
    Lee, Eunjin
    Cho, Eun Yoon
    Lee, Kwang Hee
    Bae, Soo Youn
    Lee, Se Kyung
    Kim, Seok Won
    Lee, Jeong Eon
    Nam, Seok Jin
    Ahn, Jin Seok
    Im, Young-Hyuck
    Park, Yeon Hee
    CANCER RESEARCH AND TREATMENT, 2016, 48 (04): : 1338 - 1350
  • [26] Differential enrichment of pathways in association with TP53 mutation status of breast cancers
    Joshi, H. N.
    Langerod, A.
    Troyanskaya, O. G.
    Borresen-Dale, A. L.
    Kristensen, V. N.
    EJC SUPPLEMENTS, 2010, 8 (05): : 204 - 204
  • [27] Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment
    Ungerleider, Nathan A.
    Rao, Sonia G.
    Shahbandi, Ashkan
    Yee, Douglas
    Niu, Tianhua
    Frey, Wesley D.
    Jackson, James G.
    BREAST CANCER RESEARCH, 2018, 20
  • [28] Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment
    Nathan A. Ungerleider
    Sonia G. Rao
    Ashkan Shahbandi
    Douglas Yee
    Tianhua Niu
    Wesley D. Frey
    James G. Jackson
    Breast Cancer Research, 20
  • [30] Expression signature of p53 status (p53 signature) for the prediction of TP53 mutation and prognosis in breast cancer.
    Ishioka, C.
    Takahashi, S.
    Ishida, T.
    Moriya, T.
    Ohuchi, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 40S - 40S